Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies

The incidence of esophageal adenocarcinoma (EAC) has rapidly increased, particularly in the Western world. Despite improvements in perioperative treatments, the overall survival of patients remains low. Claudin 18.2 is a tight junction protein that is exclusively expressed in the gastric epithelia....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Autores principales: Moentenich, Valeska, Gebauer, Florian, Comut, Erdem, Tuchscherer, Armin, Bruns, Christiane, Schroeder, Wolfgang, Buettner, Reinhard, Alakus, Hakan, Loeser, Heike, Zander, Thomas, Quaas, Alexander
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204493/
https://ncbi.nlm.nih.gov/pubmed/32391091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11520
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares